Screening and comorbidity of clinical levels of fear of cancer recurrence

详细信息    查看全文

• 作者：Sébastien Simard ; Josée Savard
• 关键词：Cancer ; Fear of cancer recurrence ; Fear of progression ; Screening ; Clinical levels ; Comorbidity ; Psychiatric disorders
• 刊名：Journal of Cancer Survivorship
• 出版年：2015
• 出版时间：September 2015
• 年：2015
• 卷：9
• 期：3
• 页码：481-491
• 全文大小：280 KB
• 参考文献：1.Vickberg SMJ. The Concerns About Recurrence Scale (CARS): a systematic measure of women’s fears about the possibily of breast cancer reccurrence. Ann Behav Med. 2003;25(1):16-4.View Article PubMed
  2.Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Suppl):2565-6.View Article PubMed
  3.Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7(3):300-2.View Article PubMed
  4.LeeJones C, Humphris G, Dixon R, Hatcher MB. Fear of cancer recurrence—a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears. Psychooncology. 1997;6(2):95-05.View Article
  5.Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long‐term (??years) cancer survivors—a systematic review of quantitative studies. Psychooncology. 2013;22(1):1-1.View Article PubMed
  6.Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: a systematic review. Psychooncology. 2013;22(5):978-6.View Article PubMed
  7.Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D. Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Surg. 2003;32(5):486-1.View Article PubMed
  8.Mast ME. Survivors of breast cancer: illness uncertainty, positive reappraisal, and emotional distress. Oncol Nurs Forum. 1998;25(3):555-2.PubMed
  9.Koch L, Bertram H, Eberle A, Holleczek B, Schmid-H?pfner S, Waldmann A, et al. Fear of recurrence in long-term breast cancer survivors—still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the Cancer Survivorship—a multi-regional population-based study. Psychooncology. 2014;23(5):547-4.View Article PubMed
  10.Hart SL, Latini DM, Cowan JE, Carroll PR. Fear of recurrence, treatment satisfaction, and quality of life after radical prostatectomy for prostate cancer. Support Care Cancer. 2008;16(2):161-.View Article PubMed
  11.Simard S, Savard J. Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2009;17(3):241-1.View Article PubMed
  12.Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21(6):571-7.View Article PubMed
  13.Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID). New York: Biometrics Research Department, New-York State Psychiatric Institute; 1997.
  14.Antony MM, Rowa K. Evidence-based assessment of anxiety disorders in adults. Psychol Assess. 2005;17(3):256-6.View Article PubMed
  15.Hogan TP. Psychological testing: a practical introduction, 2nd ed. Hoboken; 2007.
  16.Davison TE, McCabe MP, Mellor D. An examination of the “gold standard-diagnosis of major depression in aged-care settings. Am J Geriatr Psychiatr. 2009;17(5):359-7.View Article
  17.Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, et al. The diagnostic role of a short screening tool-the distress thermometer: a meta-analysis. Support Care Cancer. 2014;22(7):1741-5.View Article PubMed
  18.Murphy JM, Berwick DM, Weinstein MC, Borus JF, Budman SH, Klerman GL. Performance of screening and diagnostic tests. Application of receiver operating characteristic analysis. Arch Gen Psychiatr. 1987;44(6):550-.View Article PubMed
  19.Zwahlen D, Hagenbuch N, Carley MI, Recklitis CJ, Buchi S. Screening cancer patients-families with the distress thermometer (DT): a validation study. Psychooncology. 2008;17(10):959-6.View Article PubMed
  20.Skaali T, Fossa SD, Bremnes R, Dahl O, Haaland CF, Hauge ER, et al. Fear of recurrence in long-term testicular cancer survivors. Psychooncology. 2009;18(6):580-.View Article PubMed
  21.Mirabeau-Beale KL, Kornblith AB, Penson RT, Lee H, Goodman A, Campos SM, et al. Comparison of the quality of life of early and advanced stage ovarian cancer survivors. Gynecol Oncol. 2009;114(2):353-.View Article PubMed
  22.Matulonis UA, Kornblith A, Lee H, Bryan J, Gibson C, Wells C, et al. Long-term adjustment of early-stage ovarian cancer survivors. Int J Gynecol Cancer. 2008;18(6):1183-3.View Article PubMed
  23.Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273-0.View Article PubMed
  24.Roth A, Nelson CJ, Rosenfeld B, Warshowski A, O’Shea N, Scher H, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics. 2006;47(4):340-.View Article PubMed
  25.Simard S, Savard J, Ivers H. Fear
• 作者单位：Sébastien Simard (1) (2)
  Josée Savard (3) (4)
  
  1. Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), 2725, Chemin Ste-Foy, Québec, G1V 4G5, QC, Canada
  2. Nursing Faculty, Université Laval, Québec, QC, Canada
  3. School of Psychology, Université Laval, Québec, QC, Canada
  4. Laval University Cancer Research Center, Québec, QC, Canada
  
• 刊物主题：Public Health; Oncology; Health Promotion and Disease Prevention; Health Informatics; Quality of Life Research; Primary Care Medicine;
• 出版者：Springer US
• ISSN：1932-2267

文摘

Purpose The prevalence of clinical levels of fear of cancer recurrence (FCR) in cancer survivors is unknown, which may be partly explained by the lack of an assessment method that would make it possible to distinguish between normal and clinical levels of FCR. Moreover, despite the apparent overlap between FCR and manifestations of some psychiatric disorders, no study has yet evaluated the comorbidity of clinical levels of FCR. The goals of this study were to assess the capacity of the Fear of Cancer Recurrence Inventory severity subscale, to consider a shorter form of the FCRI (FCRI-SF), to screen for clinical levels of FCR, and to assess its psychiatric comorbidity. Methods Sixty French-Canadian cancer survivors (73?% of those eligible) who had been treated within the past 4?years for localized breast, prostate, lung, or colorectal cancer were randomly selected. Participants were administered a clinical interview assessing FCR, the Structured Clinical Interview for DSM-IV, and self-report scales. Results A cutoff score of 13 or higher on the FCRI-SF was associated with optimal sensitivity (88?%) and specificity (75?%) rates for the screening of clinical levels of FCR. Cancer survivors with clinical levels of FCR were significantly more likely to meet the criteria for a current psychiatric disorder (60?%) than patients with nonclinical levels (29?%). Anxiety disorders tended to be the most common comorbid disorders. Conclusions/Implications for Cancer Survivors The FCRI-SF allows rapid and effective screening of clinical levels of FCR, a condition associated with significant psychiatric comorbidity.